Zosano Pharma Corp Operating Lease, Payments
Zosano Pharma Corp reported Operating Lease, Payments of $508.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2022-05-13
- Zosano Pharma Corp operating lease, payments for the quarter ending 2022-03-31 was $508.00K, a 3.89% increase year-over-year.
- Zosano Pharma Corp operating lease, payments for the quarter ending 2021-12-31 was $503.00K, a 2.86% increase year-over-year.
- Zosano Pharma Corp operating lease, payments for the quarter ending 2021-09-30 was $495.00K, a 6.22% increase year-over-year.
- Zosano Pharma Corp operating lease, payments for the quarter ending 2021-06-30 was $489.00K, a 6.07% increase year-over-year.
- Zosano Pharma Corp operating lease, payments for fiscal 2021 was $1.98M, a 5.27% increase from fiscal 2020.
- Zosano Pharma Corp operating lease, payments for fiscal 2020 was $1.88M, a 4.68% increase from fiscal 2019.
- Zosano Pharma Corp operating lease, payments for fiscal 2019 was $1.79M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2022-03-31 | $508.00K 10-Q · filed 2022-05-13 | $1.01M derived: sum of 2 quarters · filed 2022-05-13 | $1.51M derived: sum of 3 quarters · filed 2022-05-13 | $2.00M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | $503.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $998.00K derived: sum of 2 quarters · filed 2022-03-17 | $1.49M derived: sum of 3 quarters · filed 2022-03-17 | $1.98M 10-K · filed 2022-03-17 |
| 2021-09-30 | $495.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $984.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.47M 10-Q · filed 2021-11-10 | $1.96M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | $489.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $978.00K 10-Q · filed 2021-08-10 | $1.47M derived: sum of 3 quarters · filed 2022-05-13 | $1.93M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | $489.00K 10-Q · filed 2022-05-13 | $978.00K derived: sum of 2 quarters · filed 2022-05-13 | $1.44M derived: sum of 3 quarters · filed 2022-05-13 | $1.91M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $489.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $955.00K derived: sum of 2 quarters · filed 2022-03-17 | $1.42M derived: sum of 3 quarters · filed 2022-03-17 | $1.88M 10-K · filed 2022-03-17 |
| 2020-09-30 | $466.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $927.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.39M 10-Q · filed 2021-11-10 | $1.85M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $461.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $922.00K 10-Q · filed 2021-08-10 | $1.38M derived: sum of 3 quarters · filed 2021-08-10 | $1.84M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $461.00K 10-Q · filed 2021-05-12 | $922.00K derived: sum of 2 quarters · filed 2021-05-12 | $1.38M derived: sum of 3 quarters · filed 2021-05-12 | $1.82M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $461.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $921.00K derived: sum of 2 quarters · filed 2021-03-11 | $1.36M derived: sum of 3 quarters · filed 2021-03-11 | $1.79M 10-K · filed 2021-03-11 |
| 2019-09-30 | $460.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $896.00K derived: sum of 2 quarters · filed 2020-11-13 | $1.33M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $436.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $872.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $436.00K 10-Q · filed 2020-05-14 |